Celltrion and Samsung Bioepis Take Divergent Paths in the Global Biosimilar Race

SEOUL, Dec. 26 (Korea Bizwire) — South Korea’s two leading biosimilar makers, Celltrion and Samsung Bioepis, are converging in global scale but diverging sharply in how they produce and sell their medicines, according to a new industry analysis released this week. A report by Korea Ratings said the contrasting strategies have become a defining feature of [...]